Live Chat

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

JnJ live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Info

Spread

0.97

Spread (%)

0.6389 %

Leverage

1:2

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Thursday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

368943726592

Shares Outstanding

2407620096

Earnings Date (Next)

2001-06-13

Div Yield

2024-12-10

Ex-Dividend Date

2024-11-26

Forward annual dividend rate

4.96

Forward annual dividend yield

0.0325

EPS

6.07

Learn more about this instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest news

Stay updated with the latest financial news from around the world.

Dogecoin surges

Wednesday, 13 November 2024

Dogecoin surges as Trump unveils new government efficiency initiative with Musk andRamaswamy

Wednesday, 13 November 2024

Japanese Yen to USD: Yen drops to fresh multi-month low against USD

Wednesday, 13 November 2024

Asia markets today: Nikkei 225 up 0.18%, Hang Seng Index falls by 197 points

Tuesday, 12 November 2024

UK stock market news: Helium One share price trading 16.1% higher

Tuesday, 12 November 2024

Leveraged ETF to package Warren Buffett's Berkshire Hathaway B stock

Tuesday, 12 November 2024

Dogecoin surges 20% after Department of Government Efficiency announcement

Tuesday, 12 November 2024

Dow Jones Dips Ahead of CPI Inflation Data; Tesla shares up

Monday, 11 November 2024

Stock market today: Trump trade powers Dow Johns, S&P 500, Tesla and bitcoin

Trustpilot
Live Chat